Both in Biotechnology
C4 Therapeutics vs Surrozen
Over the past year CCCC returned +29.1% and SRZN returned +107.4%; their daily moves had a correlation of 0.20.
CCCC +29.1% SRZN +107.4%Growth of $1, one year, split-adjusted
| Metric | CCCC | SRZN |
|---|---|---|
| Price | $3.37 | $29.04 |
| Market cap | $414.6M | $341.3M |
| Today | +2.12% | −1.43% |
| 1 month | +7.3% | −3.2% |
| 6 months | +15.4% | −13.6% |
| Year to date | +76.4% | +28.5% |
| 1 year | +34.3% | +113.7% |
| Revenue growth (YoY) | +2.8% | +408.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −355.9% | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 29.7× |
| Net cash | $253.7M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.1% | 174.0% |
| Short % of float | 43.4% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).